Wexford Laboratories Private Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Wexford Laboratories Private Limited Pharmaceutical Export Portfolio Dataset — 11 Products, $31.5M FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Wexford Laboratories Private Limited — Pharmaceutical Exporter Profile (2026) | 11 Products, $31.5M Trade | TransData Nexus

Wexford Laboratories Private Limited

Indian Pharmaceutical Exporter · Antibiotics Specialist · $31.5M Total Trade · DGFT Verified

Wexford Laboratories Private Limited is an Indian pharmaceutical exporter with a total trade value of $31.5M across 11 products in 7 therapeutic categories. Based on 745 verified export shipments from Indian Customs (DGFT) records, Wexford Laboratories Private Limited is the #1 Indian exporter in 1 product including Ambroxol. Top exports include Amoxicillin ($10.3M), Omeprazole ($5.0M), Ibuprofen ($4.2M).

Wexford Laboratories Private Limited — Export Portfolio & Destination Treemap

Wexford Laboratories Private Limited pharmaceutical export portfolio — 11 products across 7 therapeutic categories. Source: Indian Customs (DGFT).

Who is Wexford Laboratories Private Limited? — Company Overview & Market Position

Wexford Laboratories Private Limited, established on August 2, 2002, is a privately held pharmaceutical company headquartered in Tumkur, Karnataka, India. The company is registered under the Corporate Identification Number (CIN) U24231KA2002PTC030849. As of the latest available data, Wexford Laboratories has an authorized capital of ₹7.5 million and a paid-up capital of ₹7.22 million. The company employs approximately 151 professionals. Wexford Laboratories specializes in the manufacturing of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections, adhering to WHO-GMP standards.

What Does Wexford Laboratories Private Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Amoxicillin$10.3M 2Omeprazole$5.0M

Product Portfolio — Top 11 by Export Value

Wexford Laboratories Private Limited exports 11 pharmaceutical products across 7 therapeutic categories. Market leader (#1 exporter) in 1 products.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Amoxicillin	Antibiotics	$10.3M	207	1.7%	7
2	Omeprazole	Gastrointestinal	$5.0M	100	0.8%	14
3	Ibuprofen	Analgesics & Antipyretics	$4.2M	83	0.7%	12
4	Loratadine	Antihistamines & Allergy	$2.7M	54	1.6%	5
5	Enalapril	Cardiovascular	$1.9M	38	0.8%	5
6	Clarithromycin	Antibiotics	$1.8M	35	1.8%	6
7	Ambroxol	Respiratory & OTC	$1.4M	28	9.5%	1
8	Ketorolac	Analgesics & Antipyretics	$1.1M	50	1.0%	8
9	Levofloxacin	Antibiotics	$1.1M	88	1.5%	13
10	Fluconazole	Antifungals	$1.0M	42	1.1%	15
11	Cephalexin	Antibiotics	$1.0M	20	0.3%	7

Wexford Laboratories Private Limited exports 11 pharmaceutical products across 7 therapeutic categories with a total export value of $31.5M. The company is the #1 Indian exporter in 1 product: Ambroxol. The top category is Antibiotics (45.0% of portfolio), followed by Analgesics & Antipyretics (16.8%), indicating a concentrated portfolio with the top 5 products accounting for 76.6% of total export value.

Wexford Laboratories Private Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Wexford Laboratories operates multiple manufacturing facilities in Tumkur, Karnataka, India. These facilities are dedicated to various pharmaceutical formulations, including general products, penicillin and cephalosporin oral solid dosage forms, and sterile formulations. The company emphasizes compliance with WHO-GMP standards across its manufacturing processes.

3Key Leadership

The leadership team at Wexford Laboratories includes:

Bini Deepak: Director, appointed on November 4, 2002.

Deepak Badrinarayan: Director, appointed on August 2, 2002.

These individuals have been instrumental in steering the company's strategic direction and operations.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Wexford Laboratories Private Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Wexford Laboratories has established a significant presence in regulated markets, particularly in Latin America. The company exports a diverse range of pharmaceutical formulations, including tablets, capsules, topicals, liquid orals, dry syrups, ophthalmic solutions, and injectables. These products comply with WHO-GMP standards, facilitating market access in these regions.

2Emerging Markets

Wexford Laboratories has expanded its reach into emerging markets, notably in Africa, Latin America, Southeast Asia, and other regions. The company's adherence to WHO-GMP standards has been pivotal in obtaining necessary regulatory approvals, thereby enhancing its market penetration in these areas.

3Geographic Strategy

Wexford Laboratories has strategically diversified its export markets, focusing on regions such as Latin America, Africa, and Southeast Asia. This diversification mitigates concentration risk and positions the company to leverage growth opportunities across various geographies. The company's adherence to WHO-GMP standards has been instrumental in facilitating market access and regulatory approvals in these regions.

Wexford Laboratories Private Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

As of the latest available data, Wexford Laboratories has not reported any FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), or Drug Master File (DMF) filings. There is no publicly available information regarding FDA inspections or compliance history for the company. This suggests that Wexford Laboratories may not currently have a direct presence in the U.S. market.

2WHO & EU GMP

Wexford Laboratories manufactures pharmaceutical formulations in compliance with WHO-GMP standards. However, there is no publicly available information confirming the company's possession of WHO prequalification, EU GMP certificates, or EDQM status. This indicates that while the company adheres to WHO-GMP standards, it may not have obtained specific certifications from WHO or the European Directorate for the Quality of Medicines & HealthCare (EDQM).

3CDSCO & Indian Regulatory

Wexford Laboratories holds manufacturing licenses from the Central Drugs Standard Control Organisation (CDSCO) in India. The company has also obtained necessary approvals from state drug controllers and export No Objection Certificates (NOCs) to facilitate its export operations. These regulatory compliances ensure that the company's products meet the required standards for domestic and international markets.

Wexford Laboratories Private Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Wexford Laboratories operates in a competitive pharmaceutical export market, with key competitors including established Indian pharmaceutical companies such as Sun Pharmaceutical Industries, Dr. Reddy's Laboratories, and Cipla. While specific market share data is not publicly available, Wexford Laboratories' focus on WHO-GMP compliant formulations and its strategic presence in emerging markets position it as a competitive player in the industry.

2Key Differentiators

Wexford Laboratories' key differentiators include its adherence to WHO-GMP standards, a diverse product portfolio encompassing various pharmaceutical formulations, and a strategic focus on emerging markets. These factors enable the company to offer high-quality products and effectively meet the needs of its international clientele.

3Strategic Position

Wexford Laboratories is strategically positioned as a fully integrated pharmaceutical company, focusing on the export of generic and branded products. The company's adherence to WHO-GMP standards and its expansion into emerging markets underscore its commitment to quality and growth. Future outlooks suggest continued emphasis on market diversification and compliance with international regulatory standards to enhance global presence.

Buyer Due Diligence Brief — Evaluating Wexford Laboratories Private Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Wexford Laboratories has demonstrated a consistent track record in pharmaceutical manufacturing, with a diverse product portfolio and a strategic focus on emerging markets. The company's adherence to WHO-GMP standards and its expansion into various geographies indicate reliability and a commitment to quality. However, the lack of specific certifications such as WHO prequalification and EU GMP certificates may be a consideration for potential partners.

2Certifications to Verify

Importers should verify the following certifications when considering Wexford Laboratories as a supplier:

WHO-GMP Certification: To ensure compliance with World Health Organization Good Manufacturing Practices.

EU GMP Certification: To confirm adherence to European Union Good Manufacturing Practices.

ISO Certifications: To assess the company's quality management systems.

Frequently Asked Questions — Wexford Laboratories Private Limited

How many pharmaceutical products does Wexford Laboratories Private Limited export from India?

Wexford Laboratories Private Limited exports 11 pharmaceutical products across 7 therapeutic categories. The top exports are Amoxicillin ($10.3M), Omeprazole ($5.0M), Ibuprofen ($4.2M), Loratadine ($2.7M), Enalapril ($1.9M). Total export value is $31.5M.

What is Wexford Laboratories Private Limited's total pharmaceutical export value?

Wexford Laboratories Private Limited's total pharmaceutical export value is $31.5M, based on 745 verified shipments recorded in Indian Customs (DGFT) data.

In which products is Wexford Laboratories Private Limited the #1 Indian exporter?

Wexford Laboratories Private Limited is the #1 Indian exporter in 1 products: Ambroxol (9.5% market share).

What therapeutic categories does Wexford Laboratories Private Limited cover?

Wexford Laboratories Private Limited exports across 7 therapeutic categories. The largest are Antibiotics (45.0%, 4 products), Analgesics & Antipyretics (16.8%, 2 products), Gastrointestinal (15.9%, 1 products).

Get Full Wexford Laboratories Private Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.